{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:23:23Z","timestamp":1785536603856,"version":"3.56.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.588773","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T06:47:10Z","timestamp":1602658030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar"],"prefix":"10.3389","volume":"11","author":[{"given":"Mikkel Bo","family":"Brent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Skovhus","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Br\u00fcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1196\/annals.1365.035","article-title":"Bone remodeling","volume-title":"Annals of the New York Academy of Sciences","author":"Hadjidakis","year":"2006"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-198305000-00047","article-title":"A determinant of bone architecture. The minimum effective strain","volume":"175","author":"Frost","year":"1983","journal-title":"Clin Orthop Relat Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/archinte.1996.00440120051005","article-title":"Osteoporosis","volume":"156","author":"Ross","year":"1996","journal-title":"Arch Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650050807","article-title":"Bone mineral loss and recovery after 17 weeks of bed rest","volume":"5","author":"Leblanc","year":"1990","journal-title":"J Bone Miner Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/10790268.2006.11753898","article-title":"Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies","volume":"29","author":"Giangregorio","year":"2006","journal-title":"J Spinal Cord Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/463675","article-title":"Therapy of Osteoporosis in Men with Teriparatide","volume":"2011","author":"Cusano","year":"2011","journal-title":"J Osteoporos"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1759720X19877994","article-title":"Update on the safety and efficacy of teriparatide in the treatment of osteoporosis","volume":"11","author":"Minisola","year":"2019","journal-title":"Ther Adv Musculoskel Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1006\/bulm.1999.0146","article-title":"Parathyroid hormone temporal effects on bone formation and resorption","volume":"62","author":"Kroll","year":"2000","journal-title":"Bull Math Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","article-title":"Primary hyperparathyroidism and the skeleton","volume":"69","author":"Mosekilde","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.02.017","article-title":"PTH (1\u201334) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats","volume":"110","author":"Brent","year":"2018","journal-title":"Bone"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.10.037","article-title":"Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts","volume":"44","author":"Jilka","year":"2009","journal-title":"Bone"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1300","DOI":"10.7759\/cureus.1300","article-title":"Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis","volume":"9","author":"Tella","year":"2017","journal-title":"Cureus"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-010-0465-9","article-title":"Molecular basis of parathyroid hormone receptor signaling and trafficking: A family B GPCR paradigm","volume":"68","author":"Vilardaga","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: Anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B17","first-page":"18","article-title":"The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics","volume":"34","author":"Lombardi","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.022905","article-title":"Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides","volume":"284","author":"Pioszak","year":"2009","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0274","article-title":"Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH\/PTHrP receptor","volume":"22","author":"Dean","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1301674110","article-title":"Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH","volume":"110","author":"Maeda","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on newvertebral fractures in postmenopausalwomen with osteoporosis a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA - J Am Med Assoc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/jc.2014-3718","article-title":"Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis","volume":"100","author":"Leder","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2265.1992.tb02279.x","article-title":"Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism","volume":"37","author":"Rosenqvist","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960110205","article-title":"QT intervals as an index of high serum calcium in hypercalcemia","volume":"11","author":"Saikawa","year":"1988","journal-title":"Clin Cardiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2018.1523771","article-title":"Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models","volume":"89","author":"Bernhardsson","year":"2018","journal-title":"Acta Orthop"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00309-4","article-title":"In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment","volume":"27","author":"Stanislaus","year":"2000","journal-title":"Bone"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2012.11.037","article-title":"PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats","volume":"53","author":"Br\u00fcel","year":"2013","journal-title":"Bone"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.08.009","article-title":"Botox induced muscle paralysis rapidly degrades bone","volume":"38","author":"Warner","year":"2006","journal-title":"Bone"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"NC3Rs Reporting Guidelines Working Group. Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-017-0830-y","article-title":"Disuse osteopenia induced by botulinum toxin is similar in skeletally mature young and aged female C57BL\/6J mice","volume":"36","author":"Vegger","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115183","article-title":"Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice","volume":"131","author":"S\u00f8rensen","year":"2020","journal-title":"Bone"},{"key":"B35","first-page":"79","article-title":"Neuromuscular dysfunction, independent of gait dysfunction, modulates trabecular bone homeostasis in mice","volume":"19","author":"Bain","year":"2019","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B36","article-title":"Pantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice","volume":"17","author":"Vegger","year":"2017","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-015-0035-0","article-title":"Vertical Trabeculae are Thinned More Than Horizontal Trabeculae in Skeletal-Unloaded Rats","volume":"97","author":"Vegger","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00438-5","article-title":"Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin","volume":"28","author":"Chappard","year":"2001","journal-title":"Bone"},{"key":"B39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00223-012-9576-7","article-title":"Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats","volume":"90","author":"Thomsen","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2014.06.020","article-title":"Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats","volume":"66","author":"Vegger","year":"2014","journal-title":"Bone"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-1112","article-title":"Teriparatide [rhPTH (1-34)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats","volume":"152","author":"Ma","year":"2011","journal-title":"Endocrinology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3930","article-title":"Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice","volume":"35","author":"Le Henaff","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e14225","DOI":"10.14814\/phy2.14225","article-title":"Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and \u03b2-arrestin recruitment than teriparatide","volume":"7","author":"Sahbani","year":"2019","journal-title":"Physiol Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-04999-4","article-title":"Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia","volume":"30","author":"Chandler","year":"2019","journal-title":"Osteoporos Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.11.027","article-title":"One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats","volume":"95","author":"Varela","year":"2017","journal-title":"Bone"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.10.012","article-title":"Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption","volume":"120","author":"Chandler","year":"2019","journal-title":"Bone"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.04.025","article-title":"Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis","volume":"124","author":"Besschetnova","year":"2019","journal-title":"Bone"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24254","article-title":"Abaloparatide, a PTH receptor agonist with homology to PTHrP, enhances callus bridging and biomechanical properties in rats with femoral fracture","volume":"37","author":"Lanske","year":"2019","journal-title":"J Orthop Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2009.02.012","article-title":"PTH and PTHrP signaling in osteoblasts","volume":"21","author":"Datta","year":"2009","journal-title":"Cell Signal"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92216-9","article-title":"Anabolic Effect of Low Doses of a Fragment of Human Parathyroid Hormone on the Skeleton in Postmenopausal Osteoporosis","volume":"307","author":"Reeve","year":"1976","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jbmr.3003","article-title":"One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption","volume":"32","author":"Varela","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3042","article-title":"Abaloparatide Is an Anabolic, but Does It Spare Resorption","volume":"32","author":"Martin","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.12.023","article-title":"Micro and macroarchitectural changes at the tibia after botulinum toxin injection in the growing rat","volume":"50","author":"Bouvard","year":"2012","journal-title":"Bone"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.10.015","article-title":"Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial","volume":"120","author":"Miller","year":"2019","journal-title":"Bone"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100291","article-title":"Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice","volume":"13","author":"Arlt","year":"2020","journal-title":"Bone Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s007760200063","article-title":"Comparative effects of intermittent administration of human parathyroid hormone (1-34) on cancellous and cortical bone loss in tail-suspended and sciatic neurectomized young rats","volume":"7","author":"Moriyama","year":"2002","journal-title":"J Orthop Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.588773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T06:47:13Z","timestamp":1602658033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.588773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":56,"alternative-id":["10.3389\/fendo.2020.588773"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.588773","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"article-number":"588773"}}